UK Approves Merck & Ridgeback’s Molnupiravir Oral COVID19 Antiviral Medicine | All You Need To Know

<p>
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/D-FYXPm7zLo" title="YouTube video player" width="560"></iframe></p>
<p>
<span style="background-color: rgb(249, 249, 249); color: rgb(3, 3, 3); font-family: Roboto, Arial, sans-serif; font-size: 14px; white-space: pre-wrap;">Merck & Ridgeback’s Molnupiravir, an Oral COVID19 Antiviral Medicine, has been authorized by the United Kingdom. UK has become the 1st country to recommended Molnupiravir for use in people with mild to moderate Covid19 and at least one risk factor for developing severe illness, such as obesity, older age diabetes & heart disease. Keep Watching for more such updates! </span></p>
<div>
<span style="color: rgb(3, 3, 3); font-family: Roboto, Arial, sans-serif; font-size: 14px; white-space: pre-wrap; background-color: rgb(249, 249, 249);"><br />
</span></div>